<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01502462</url>
  </required_header>
  <id_info>
    <org_study_id>Severe_Isol_TR</org_study_id>
    <nct_id>NCT01502462</nct_id>
  </id_info>
  <brief_title>Prospective Registry of Patients With Isolated Severe Tricuspid Regurgitation</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Asan Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Asan Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective registry for patients with severe isolated tricuspid regurgitation (TR) without
      significant left-sided valvular or myocardial diseases.

      Aim: To evaluate clinical course and prognostic factors of patients with severe isolated TR.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Inclusion criteria Severe isolated TR for more than 6 months

      Exclusion criteria

        1. Severe mitral and aortic valvular heart disease

        2. Age equals to or more than 75 years

        3. Malignancy or serious comorbidity with life expectancy &lt; 5years

        4. Acute or subacute infective endocarditis requiring antibiotics therapy

        5. Untreated hyperthyroidism

        6. Constrictive pericarditis

        7. Unclosed significant atrial septal defect

        8. Previous tricuspid valve surgery

        9. Significant coronary artery disease

       10. Cardiomyopathy

       11. Pregnancy

       12. Severe resting pulmonary hypertension(TR Vmax &gt;4.0 m/s)
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Anticipated">January 2022</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>all cause death</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hospitalization of cardiovascular causes</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>tricuspid valve surgery</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>stroke</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Tricuspid Regurgitation</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Prospective registry for patients with severe isolated tricuspid regurgitation (TR) without
        significant left-sided valvular or myocardial diseases.

        Aim: To evaluate clinical course and prognostic factors of patients with severe isolated TR
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria

          -  Severe isolated TR for more than 6 months

        Exclusion criteria

          1. Severe mitral and aortic valvular heart disease

          2. Age equals to or more than 75 years

          3. Malignancy or serious comorbidity with life expectancy &lt; 5years

          4. Acute or subacute infective endocarditis requiring antibiotics therapy

          5. Untreated hyperthyroidism

          6. Constrictive pericarditis

          7. Unclosed significant atrial septal defect

          8. Previous tricuspid valve surgery

          9. Significant coronary artery disease

         10. Cardiomyopathy

         11. Pregnancy

         12. Severe resting pulmonary hypertension(TR Vmax &gt;4.0 m/s)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Asan Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>138-736</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jong-Min Song, MD, PhD</last_name>
      <phone>82-2-3010-3168</phone>
      <email>jmsong@amc.seoul.kr</email>
    </contact>
    <investigator>
      <last_name>Jong-Min Song, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 29, 2011</study_first_submitted>
  <study_first_submitted_qc>December 29, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 30, 2011</study_first_posted>
  <last_update_submitted>January 9, 2018</last_update_submitted>
  <last_update_submitted_qc>January 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Asan Medical Center</investigator_affiliation>
    <investigator_full_name>Jong-Min Song</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>Clinical course and prognostic factors in patients with severe isolated TR</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tricuspid Valve Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

